Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage 3 Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02677896
What this trial is testing

Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

Who this might be right for
Metastatic Hormone Sensitive Prostate Cancer
Astellas Pharma Global Development, Inc. 1,150
Large-scale testing (Phase 3)Study completedNCT02997202
What this trial is testing

A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Astellas Pharma Global Development, Inc. 356
Testing effectiveness (Phase 2)Ended earlyNCT04240002
What this trial is testing

Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
Astellas Pharma Global Development, Inc. 9
Large-scale testing (Phase 3)Study completedNCT01282437
What this trial is testing

Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLC

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)Radical TreatmentStage III Non-Small Cell Lung Cancer
Maastricht Radiation Oncology 315
Large-scale testing (Phase 3)Active Not RecruitingNCT03803553
What this trial is testing

Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer

Who this might be right for
Metastatic Colon CancerStage III Colon Cancer
Massachusetts General Hospital 400
Testing effectiveness (Phase 2)Study completedNCT03472053
What this trial is testing

BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer Stage IIIB
BioMarck Pharmaceuticals, Ltd. 60
Not applicableStudy completedNCT02346253
What this trial is testing

High-Dose Brachytherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
Stanford University 146
Large-scale testing (Phase 3)Study completedNCT04756037
What this trial is testing

Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy

Who this might be right for
Contraception
Sumitomo Pharma Switzerland GmbH 1,164
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04211337
What this trial is testing

Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid Cancer
Loxo Oncology, Inc. 291
Testing effectiveness (Phase 2)Study completedNCT01551745
What this trial is testing

Salvage Ovarian FANG™ Vaccine + Bevacizumab

Who this might be right for
Stage III Ovarian CancerStage IV Ovarian Cancer
Gradalis, Inc. 5
Large-scale testing (Phase 3)Not Yet RecruitingNCT06146777
What this trial is testing

Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy

Who this might be right for
Papillary Renal Cell Carcinoma
First Affiliated Hospital, Sun Yat-Sen University 468
Not applicableStudy completedNCT05086731
What this trial is testing

Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+20 more
Emory University 33
Large-scale testing (Phase 3)Study completedNCT03721172
What this trial is testing

Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy

Who this might be right for
Psoriasis
Amgen 595
Early research (Phase 1)Study completedNCT00404339
What this trial is testing

Vaccine Therapy in Treating Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Robert Ferris 17
Testing effectiveness (Phase 2)Ended earlyNCT00006001
What this trial is testing

SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI) 37
Large-scale testing (Phase 3)Study completedNCT00004112
What this trial is testing

Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Nebraska
Large-scale testing (Phase 3)Active Not RecruitingNCT02319837
What this trial is testing

Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)

Who this might be right for
Hormone Sensitive Prostate CancerProstate CancerCancer of the Prostate
Pfizer 1,068
Early research (Phase 1)Study completedNCT00083057
What this trial is testing

Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
National Institutes of Health Clinical Center (CC) 30
Not applicableStudy completedNCT01366157
What this trial is testing

Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma

Who this might be right for
Lymphoma
Children's Oncology Group 23
Next Page